The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Surgical outcomes of patients with resectable non-small-cell lung cancer receiving neoadjuvant immunotherapy with nivolumab plus relatlimab or nivolumab: Findings from the prospective, randomized, multicentric phase II study NEOpredict-Lung.
 
Clemens Aigner
Consulting or Advisory Role - Ewimed
Speakers' Bureau - AstraZeneca; Biotest; Bristol-Myers Squibb; Roche
Research Funding - Bristol-Myers Squibb (Inst); PharmaCept (Inst)
 
Bert Du Pont
No Relationships to Disclose
 
Koen Hartemink
No Relationships to Disclose
 
Marcel Wiesweg
Honoraria - Amgen; AstraZeneca; GlaxoSmithKline; Janssen; Novartis; Roche; Takeda
Consulting or Advisory Role - Daiichi Sankyo; Janssen; Novartis; Pfizer; Roche
Research Funding - Bristol-Myers Squibb (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb
 
Michel Vanbockrijck
No Relationships to Disclose
 
Kaid Darwiche
Consulting or Advisory Role - bess; Boehringer Ingelheim; Boston Scientific; Broncus Medical; FreeFlow; Fujifilm; Lys Medical; Medtronic; Morair Medtech; Olympus; Pulmonx; Storz
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Boston Scientific; Broncus Medical; Erbe Elektromedizin; Olympus; Storz
Research Funding - Ambu (Inst); Broncus Medical (Inst); Epigenomics (Inst); Gala Therapeutics (Inst); Novartis (Inst); Nuvaira (Inst); PneumRx (Inst); Pulmonx (Inst); Roche (Inst)
 
Balazs Hegedus
Research Funding - Bristol-Myers Squibb (Inst)
 
Alexander Schramm
Research Funding - Bristol-Myers Squibb
 
Hubertus Hautzel
Honoraria - Urenco
Research Funding - Pari (Inst)
Travel, Accommodations, Expenses - Pari
 
Brigitte Maes
No Relationships to Disclose
 
Dirk Theegarten
No Relationships to Disclose
 
Hans-Ulrich Schildhaus
No Relationships to Disclose
 
Paul Baas
Honoraria - Bristol-Myers Squibb; MSD (Inst)
Consulting or Advisory Role - AstraZeneca (Inst); Beigene (Inst); Bristol-Myers Squibb (Inst); Merck Sharp & Dohme (Inst)
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Merck Sharp & Dohme
Other Relationship - Bristol-Myers Squibb
 
Kristof Cuppens
Consulting or Advisory Role - AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; MSD; Pfizer; Roche/Genentech
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Roche/Genentech
 
Martin H. Schuler
Honoraria - Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen-Cilag; Novartis
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline; Janssen Oncology; Merck Serono; Novartis; Roche; Sanofi; Takeda
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst)
Patents, Royalties, Other Intellectual Property - Highly sensitive method for mutation detection by PCR (Inst)
 
Till Plönes
No Relationships to Disclose